Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDxane versus Clexane for venous thromboembolism prophylaxis after major gynecologic surgery
IRCT20090914002459N2Phase 3Completed
- Sponsor
- Pooyesh Darou
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of enoxaparin in venous thromboembolism (VTE) (2 arms), sponsored by Pooyesh Darou. Primary endpoints: Effectiveness in prevention of thrombosis and/or pulmonary thromboembolism, Activated partial thromboplastin time change and 6 more. Started Feb 2016; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on IRCT20090914002459N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090914002459N2.